OLPX's liquidation posture as of March 31, 2026 is deeply negative to equity, driven by a balance sheet that is dominated by intangible assets that carry zero recovery value under liquidation accounting. Total reported assets are $1.46B, but the asset base is structurally non-recoverable on a break-up basis. Goodwill of $168.3M and net finite-lived intangibles of $834.9M together constitute approximately 69% of total assets ($1.003B combined) — all of which receive a 0% recovery haircut. Cash of $326.2M recovers at par. Net accounts receivable of $37.5M recovers at approximately 90-95% ($34-36M). Net inventory of $66.4M (against a $14.3M reserve already embedded) recovers at approximately 60% ($40M). PP&E net of $1.5M recovers at 50-70% (~$1M). Prepaid and other current assets of $16.2M have limited liquidation value, likely 0-20% ($0-3M). Estimated gross liquidation asset recovery: approximately $403-407M. Against this, liabilities at face value total $582.2M, including $354.8M face amount on the 2022 Term Loan Facility (senior secured, secured by substantially all assets of Olaplex, Inc.), $32.8M in accrued current liabilities, $29.2M accounts payable, and non-current items including $1.8M other noncurrent liabilities and deferred taxes of $0.9M. Under a liquidation scenario, the estimated shortfall to equity is approximately negative $175-179M, consistent with MFFAIS's cash liquidation value of approximately negative $97M (which appears to apply less aggressive intangible haircuts or credits some intangible recovery). The Lilien class action settlement accrual of $46.1M recorded at December 31, 2025 was released in Q1 2026 alongside its offsetting $46.8M insurance receivable — a wash at the balance sheet level with no net liquidation impact. Material post-balance-sheet development: On March 26, 2026, OLPX entered into a merger agreement with Henkel US Operations Corporation at $2.06 per share. The Tax Receivable Agreement Waiver was executed concurrently; if the merger closes, TRA obligations of $165.1M are largely extinguished. If the merger terminates, TRA obligations of $165.1M (not separately tagged as a balance sheet liability in this 10-Q XBRL — the filing discusses this obligation in MD&A and notes but does not tag it in XBRL) would re-attach as a contingent off-balance-sheet liability, materially worsening recovery to equity. The merger is subject to HSR and foreign regulatory approvals with an outside date of March 31, 2027 (extendable to September 30, 2027). A $40.4M termination fee is payable by OLPX under certain break scenarios. Neither the TRA liability nor the merger termination fee is separately XBRL-tagged in this filing.
▼ Community Notes